Altamira Therapeutics Ltd (CYTO) Stock: What Does the Chart Say Thursday?

Overall market sentiment has been high on Altamira Therapeutics Ltd (CYTO) stock lately. CYTO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Altamira Therapeutics Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CYTO!

See Full CYTO Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CYTO Stock Today?

Altamira Therapeutics Ltd (CYTO) stock is trading at $0.84 as of 9:34 AM on Thursday, Nov 30, a rise of $0.19, or 29.91% from the previous closing price of $0.64. The stock has traded between $0.78 and $0.85 so far today. Volume today is low. So far 9,637,514 shares have traded compared to average volume of 24,284,259 shares. To see InvestorsObserver's Sentiment Score for Altamira Therapeutics Ltd click here.

More About Altamira Therapeutics Ltd

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. Click Here to get the full Stock Report for Altamira Therapeutics Ltd stock.